… We aimed to assess the overall efficacy and safety of dupilumab treatment in AD. … All
randomized controlled trials (RCTs) of dupilumab treatment on adult patients with AD were included…

… that the epidermal abnormalities associated with atopic dermatitis might be reduced with
dupilumab treatment. We also found a substantial dupilumab-associated reduction in the level …

… with dupilumab treatment in 95 patients with atopic dermatitis in daily … treatment before
starting dupilumab treatment or continued the immunosuppressant during dupilumab treatment, …

… study, we report the efficacy and safety of the combination of dupilumab with phototherapy
or other systemic agents in patients who are resistant or lose response to dupilumab therapy. …

… before and after dupilumab. A, Subject-provided photograph before the start of dupilumab
therapy. B, Photograph taken in the clinic 1 year after the patient started dupilumab therapy. …

… 3 Patients with atopic dermatitis may require inpatient hospital treatment for refractory atopic
dermatitis, severe atopic dermatitis flares, or infections. In particular, cutaneous infections …

… Overall, dupilumab was well-tolerated and resulted in clinical improvement in our patient …
safety and utility of dupilumab treatment for moderate to severe atopic dermatitis in the real-…

… Dupilumab therapy also has an effect … of dupilumab and after 12 weeks of therapy with 300
mg, an 83% reduction, compared with the baseline, was observed. Also, 4 weeks of treatment …

… Patients were evaluated three times: at initiation of dupilumab treatment and 1 and 3 months
after treatment initiation (scheduled appointments for all patients in dupilumab treatment). …

… Patients with moderate to severe AD who received dupilumab treatment and achieved an …
in Eczema Area and Severity Index scores (EASI-75) at week 16 in 2 previous dupilumab …